These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32756116)

  • 1. Prognostic factors in patients with gallbladder adenocarcinoma identified using competing-risks analysis: A study of cases in the SEER database.
    Han D; Yang J; Xu F; Huang Q; Bai L; Wei YL; Kaaya RE; Wang S; Lyu J
    Medicine (Baltimore); 2020 Jul; 99(31):e21322. PubMed ID: 32756116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Nomograms to Predict Survival of Patients with Resectable Gallbladder Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Based Analysis.
    Lin Y; Chen H; Pan F
    Med Sci Monit; 2021 Mar; 27():e929106. PubMed ID: 33784268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competing-risks nomograms for predicting cause-specific mortality in parotid-gland carcinoma: A population-based analysis.
    Xu F; Feng X; Zhao F; Huang Q; Han D; Li C; Zheng S; Lyu J
    Cancer Med; 2021 Jun; 10(11):3756-3769. PubMed ID: 33960711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competing-Risks Model for Predicting the Postoperative Prognosis of Patients with Papillary Thyroid Adenocarcinoma Based on The Surveillance, Epidemiology, and End Results (SEER) Database.
    Bian F; Li C; Han D; Xu F; Lyu J
    Med Sci Monit; 2020 Jul; 26():e924045. PubMed ID: 32710734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.
    Lu Y; Zhou Y; Cao Y; Shi Z; Meng Q
    Med Sci Monit; 2019 May; 25():3683-3691. PubMed ID: 31102397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in patients with gastric adenocarcinoma using competing-risk analysis: a study of cases in the SEER database.
    Zhang X; Yang J; Huang Q; Lyu J
    Scand J Gastroenterol; 2019 Aug; 54(8):1015-1021. PubMed ID: 31382800
    [No Abstract]   [Full Text] [Related]  

  • 7. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.
    Xu F; Yang J; Han D; Huang Q; Li C; Zheng S; Wang H; Lyu J
    Technol Cancer Res Treat; 2021; 20():15330338211016371. PubMed ID: 34013802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram to predict cause-specific mortality of patients with rectal adenocarcinoma undergoing surgery: a competing risk analysis.
    Zhang X; Xu F; Bin Y; Liu T; Li Z; Guo D; Li Y; Huang Q; Lyu J; He S
    BMC Gastroenterol; 2022 Feb; 22(1):57. PubMed ID: 35144545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Factors in Patients with Rhabdomyosarcoma Using Competing-Risks Analysis: A Study of Cases in the SEER Database.
    Han D; Li C; Li X; Huang Q; Xu F; Zheng S; Wang H; Lyu J
    J Oncol; 2020; 2020():2635486. PubMed ID: 33014049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Competing Risk Analysis Study of Prognosis in Patients with Esophageal Carcinoma 2006-2015 Using Data from the Surveillance, Epidemiology, and End Results (SEER) Database.
    Yu Z; Yang J; Gao L; Huang Q; Zi H; Li X
    Med Sci Monit; 2020 Jan; 26():e918686. PubMed ID: 31966000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.
    Li J; Zheng Q; Zhao X; Zhao J; An T; Wu M; Wang Y; Zhuo M; Zhong J; Yang X; Jia B; Chen H; Dong Z; Wang J; Chi Y; Zhai X; Wang Z
    BMC Cancer; 2020 Aug; 20(1):793. PubMed ID: 32838776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
    Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
    Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competing-Risk Nomograms for Predicting the Prognosis of Patients With Infiltrating Lobular Carcinoma of the Breast.
    Xu F; Li C; Li X; Huang Q; Han D; Wang H; Zheng S; Lyu J
    Clin Breast Cancer; 2021 Dec; 21(6):e704-e714. PubMed ID: 33846097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms for Differentiated Thyroid Carcinoma Patients Based on the Eighth AJCC Staging and Competing Risks Model.
    Li C; Xu F; Huang Q; Han D; Zheng S; Wu W; Zhao F; Feng X; Lyu J
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34159295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive Risk Analysis of Prognosis in Older Adults with Sigmoid Colon Adenocarcinoma: A Population-Based Study.
    Du R; Guo J; Li J; Lyu J; Lyu L
    Cancer Control; 2024; 31():10732748241262184. PubMed ID: 38868954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of marital status in gallbladder cancer: a real-world competing risk analysis.
    Jin H; Du D; Xie Y; Jin H; Tong J; Li B; Chu W
    BMC Gastroenterol; 2024 Aug; 24(1):276. PubMed ID: 39164628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: A retrospective study in China and the SEER database.
    Jiang S; Zhao R; Li Y; Han X; Liu Z; Ge W; Dong Y; Han W
    Sci Rep; 2018 May; 8(1):7940. PubMed ID: 29786691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Evaluation for Patients over 45 Years Old with Gallbladder Adenocarcinoma Resection: A SEER-Based Nomogram Analysis.
    Li P; Song L
    Biomed Res Int; 2020; 2020():6370946. PubMed ID: 32733948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.
    Wang CY; Yang J; Zi H; Zheng ZL; Li BH; Wang Y; Ge Z; Jian GX; Lyu J; Li XD; Ren XQ
    BMC Cancer; 2020 Jan; 20(1):10. PubMed ID: 31906882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A competing risk nomogram for predicting cancer-specific death of patients with buccal mucosa cancer.
    Jiang Q; Xue D; Xin Y; Qiu J
    Oral Dis; 2021 May; 27(4):900-910. PubMed ID: 32791562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.